Cargando…
Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4
BACKGROUND: Multiple myeloma (MM) is a fatal malignancy ranking second in prevalence among hematological tumors. Continuous efforts are being made to develop innovative and more effective treatments. The preclinical evaluation of new therapies relies on the use of murine models of the disease. METHO...
Autores principales: | Mirandola, Leonardo, Yu, Yuefei, Jenkins, Marjorie R, Chiaramonte, Raffaella, Cobos, Everardo, John, Constance M, Chiriva-Internati, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189930/ https://www.ncbi.nlm.nih.gov/pubmed/21923911 http://dx.doi.org/10.1186/1471-2407-11-394 |
Ejemplares similares
-
Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma
por: Mirandola, Leonardo, et al.
Publicado: (2011) -
Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets
por: Mirandola, Leonardo, et al.
Publicado: (2014) -
Cancer Testis Antigen Vaccination Affords Long-Term Protection in a Murine Model of Ovarian Cancer
por: Chiriva-Internati, Maurizio, et al.
Publicado: (2010) -
Aging, cancer, and cancer vaccines
por: Mazzola, Paolo, et al.
Publicado: (2012) -
The pituitary tumor transforming gene 1 (PTTG-1): An immunological target for multiple myeloma
por: Chiriva-Internati, Maurizio, et al.
Publicado: (2008)